NEWS & EVENTS

September 21, 2023

OXFORD BIOMEDICA AND INSTITUT MERIEUX ENTER INTO EXCLUSIVE NEGOTIATIONS FOR THE PROPOSED ACQUISITION OF ABL EUROPE

Read more


September 18, 2023

ASEPTIC PROCESS OF VIRAL VECTOR-BASED VACCINES – KEY ASPECTS TO CONSIDER BEFORE CLINICAL MANUFACTURING

Read more


August 29, 2023

PROCESS CHARACTERIZATION OF VIRAL VECTORS: APPROACH IN CDMO CONTEXT

Read more


July 18, 2023

OVERCOMING OBSTACLES IN DOWNSTREAM BIOPROCESSING OF AAV-BASED GENE THERAPY PRODUCTS

Read more